MAP4K1 and non-small cell lung carcinoma: Zhang et al. (2024) observed that a high tumor infiltration of HPK1+ PD1+ TIM3+ CD8+ T cells was rather linked to a poor immune response of therapeutic ICB in patients with NSCLC [84].